Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer

NCT00004890 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Drug Extravasation
Kidney Cancer

Interventions

BIOLOGICAL: aldesleukin
DRUG: Biomed 101

Sponsor

BioMedicines

Collaborators

[object Object]